InvestSMART

Noxopharm Limited (ASX: NOX) - Announcements

- Current share price for NOX : $0.080

ASX company news and announcements for Noxopharm Limited (NOX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Noxopharm Limited (NOX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Noxopharm Limited (NOX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Noxopharm Limited (NOX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Pause in Trading 3 Oct 2023 1:21PM $0.062 $0.080 risen by 29.03%
$25 Latest CRO-67 data shows success in reducing cancer growth 28 Sep 2023 8:32AM $0.038 $0.080 risen by 110.53%
$25 2023 AGM Notice of Meeting and Proxy 28 Sep 2023 8:28AM $0.038 $0.080 risen by 110.53%
$25 2023 AGM Letter to Shareholders and Proxy 28 Sep 2023 8:26AM $0.038 $0.080 risen by 110.53%
$25 Annual Report to shareholders 27 Sep 2023 1:57PM $0.039 $0.080 risen by 105.13%
$25 Change of Director's Interest Notice - FB 21 Sep 2023 8:18AM $0.040 $0.080 risen by 100%
$25 Change of Director's Interest Notice - FB 18 Sep 2023 8:21AM $0.035 $0.080 risen by 128.57%
$25 Appendix 4E and Audited Financial Statements 31 Aug 2023 2:07PM $0.036 $0.080 risen by 122.22%
$25 Appendix 4G and Corporate Governance Statement 31 Aug 2023 2:05PM $0.036 $0.080 risen by 122.22%
$25 Notification of cessation of securities - NOX 24 Jul 2023 9:08AM $0.037 $0.080 risen by 116.22%
$25 June 2023 Activities Report and Appendix 4C 14 Jul 2023 8:19AM $0.038 $0.080 risen by 110.53%
$25 Upcoming Expiry of Listed Options (ASX Code NOXOA) 5 Jul 2023 4:29PM $0.044 $0.080 risen by 81.82%
$25 Unlisted Options expiring on 23 July 2023 5 Jul 2023 4:13PM $0.044 $0.080 risen by 81.82%
$25 Notification of cessation of securities - NOX 5 Jul 2023 4:06PM $0.044 $0.080 risen by 81.82%
$25 Change of Director's Interest Notice - FB 3 Jul 2023 1:14PM $0.044 $0.080 risen by 81.82%
$25 Change of Director's Interest Notice - FB 29 Jun 2023 12:08PM $0.039 $0.080 risen by 105.13%
$25 Change of Director's Interest Notice - FB 19 Jun 2023 7:08PM $0.058 $0.080 risen by 37.93%
$25 Change of Director's Interest Notice - BP 19 Jun 2023 7:08PM $0.058 $0.080 risen by 37.93%
$25 Change of Director's Interest Notice - PM 19 Jun 2023 7:06PM $0.058 $0.080 risen by 37.93%
$25 Details of Company Address 19 Jun 2023 10:50AM $0.060 $0.080 risen by 33.33%
$25 IONIC Trial Abstract Published at ASCO 26 May 2023 8:20AM $0.049 $0.080 risen by 64.95%
$25 Study results show new Sofra drug reduces inflammation 19 May 2023 8:19AM $0.048 $0.080 risen by 66.67%
$25 Innovative Sofra research presented at European event 18 May 2023 8:16AM $0.051 $0.080 risen by 56.86%
$25 Change of Director's Interest Notice - FB 10 May 2023 8:19AM $0.041 $0.080 risen by 95.12%
$25 Upcoming Expiry of Listed Options (ASX Code NOXO) 8 May 2023 8:54AM $0.054 $0.080 risen by 48.15%

126 - 150 of 794 results

Page 6 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.